Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dementia of Alzheimer's Type”

162 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 162 results

Large-scale testing (Phase 3)Study completedNCT00338117
What this trial is testing

Safety and Efficacy of High Dose, Rapid Titration Galantamine in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseDementia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 554
Post-approval studies (Phase 4)Study completedNCT00505167
What this trial is testing

Memantine Versus Donepezil in Early Stages of Alzheimer's Disease

Who this might be right for
Dementia, Alzheimer Type
Hospital Miguel Servet 64
Early research (Phase 1)Study completedNCT00411580
What this trial is testing

Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
Novartis Pharmaceuticals 58
Not applicableActive Not RecruitingNCT05779839
What this trial is testing

Caregiver Connections Via Technology in Dementia

Who this might be right for
Caregiver StressDementiaAlzheimer Disease+3 more
Mayo Clinic 355
Large-scale testing (Phase 3)Study completedNCT02442765
What this trial is testing

Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's Type
Otsuka Pharmaceutical Development & Commercialization, Inc. 387
Testing effectiveness (Phase 2)Study completedNCT02727699
What this trial is testing

A Phase II Study to Assess the Safety, Tolerability and Efficacy of Xanamem™ in Subjects With Mild Dementia Due to AD (XanADu)

Who this might be right for
Dementia, Alzheimer Type
Actinogen Medical 185
Large-scale testing (Phase 3)Study completedNCT00104013
What this trial is testing

Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

Who this might be right for
Alzheimer Disease
Sanofi 1,455
Early research (Phase 1)Study completedNCT01297218
What this trial is testing

The Safety and The Efficacy Evaluation of NEUROSTEM®-AD in Patients With Alzheimer's Disease

Who this might be right for
Dementia of the Alzheimer's Type
Medipost Co Ltd. 9
Testing effectiveness (Phase 2)Study completedNCT01466088
What this trial is testing

Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD)

Who this might be right for
Alzheimer's Disease
Targacept Inc. 386
Large-scale testing (Phase 3)Active Not RecruitingNCT05397639
What this trial is testing

Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type

Who this might be right for
AgitationAlzheimer's Type Dementia
Suven Life Sciences Limited 375
Testing effectiveness (Phase 2)Looking for participantsNCT06362707
What this trial is testing

Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD)

Who this might be right for
Cognitive Decline, MildAlzheimer Disease
Helse Stavanger HF 200
Large-scale testing (Phase 3)Study completedNCT04488419
What this trial is testing

ATH-1017 for Treatment of Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementia of Alzheimer Type
LeonaBio 554
Early research (Phase 1)Study completedNCT00203320
What this trial is testing

TNF-Alpha Inhibition for Treatment of Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Tobinick, Edward Lewis, M.D. 30
Large-scale testing (Phase 3)Study completedNCT00041678
What this trial is testing

Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type

Who this might be right for
Alzheimer Disease
Otsuka Pharmaceutical Development & Commercialization, Inc.
Testing effectiveness (Phase 2)UnknownNCT00154635
What this trial is testing

Efficacy and Safety Study of DCB-AD1 in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Dementia, Alzheimer Type
National Taiwan University Hospital 80
Not applicableActive Not RecruitingNCT03556280
What this trial is testing

Multi-Center Study of Sensory Stimulation to Improve Brain Function

Who this might be right for
Alzheimer DiseaseCognitive ImpairmentMild Cognitive Impairment+7 more
Cognito Therapeutics, Inc. 60
Post-approval studies (Phase 4)Study completedNCT01478633
What this trial is testing

Evaluation of Efficacy and Safety of Galantamine in Patients With Dementia of Alzheimer's Type Who Failed to Benefit From Donepezil

Who this might be right for
Alzheimer's Disease
Janssen Pharmaceutical K.K. 102
Testing effectiveness (Phase 2)Study completedNCT00842816
What this trial is testing

Preliminary Efficacy and Safety Study of ST101 Plus Aricept in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Sonexa Therapeutics, Inc. 210
Not applicableLooking for participantsNCT06339190
What this trial is testing

Neurofilament Light Chain And Voice Acoustic Analyses In Dementia Diagnosis

Who this might be right for
Neurodegenerative DiseasesDementia
Monash University 1,000
Testing effectiveness (Phase 2)Study completedNCT00470418
What this trial is testing

Development of NIC5-15 in the Treatment of Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementia
VA Office of Research and Development 15
Next Page